標題: Titlebook: Chemokines; Chemokines and Their Nuska Tschammer Book 2015 Springer International Publishing Switzerland 2015 Allosteric Modulation.CXCR3 T [打印本頁] 作者: 從未沮喪 時間: 2025-3-21 17:38
書目名稱Chemokines影響因子(影響力)
書目名稱Chemokines影響因子(影響力)學科排名
書目名稱Chemokines網絡公開度
書目名稱Chemokines網絡公開度學科排名
書目名稱Chemokines被引頻次
書目名稱Chemokines被引頻次學科排名
書目名稱Chemokines年度引用
書目名稱Chemokines年度引用學科排名
書目名稱Chemokines讀者反饋
書目名稱Chemokines讀者反饋學科排名
作者: 去才蔑視 時間: 2025-3-21 23:25
Nuska TschammerOverview chapters introduce the newcomer to the topic covered.Series covers hot topics of frontier research summarized by reputed scientists in the field.Volumes are useful and of relevance for a long作者: Oversee 時間: 2025-3-22 02:57
Topics in Medicinal Chemistryhttp://image.papertrans.cn/c/image/224912.jpg作者: BILE 時間: 2025-3-22 05:42 作者: 繁忙 時間: 2025-3-22 09:24 作者: 藝術 時間: 2025-3-22 16:37
,Einflu? des Stichprobenumfangs n,coupled receptors, which represent one of the most druggable classes of proteins. In this review we will examine the role of chemokines in autoimmunity and inflammation by concentrating on the part they play in the pathophysiology of several diseases including asthma, multiple sclerosis, and rheumat作者: 藝術 時間: 2025-3-22 20:18 作者: 戲法 時間: 2025-3-22 23:55 作者: 曲解 時間: 2025-3-23 05:24
https://doi.org/10.1007/978-3-322-87917-2ng evidence for a role of CCR2 and CCR5 receptors in human inflammatory diseases led to a growing interest in CCR2- and CCR5-selective antagonists. In this review, we focus on the recent development of selective CCR2/CCR5 receptor ligands and dual antagonists. Several compounds targeting CCR2, e.g.,作者: 開花期女 時間: 2025-3-23 06:59 作者: 輕信 時間: 2025-3-23 10:06
Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview,ory processes fueled the use of CCR5 antagonists for the treatment of rheumatoid arthritis. Unfortunately, the use of maraviroc for the treatment of rheumatoid arthritis failed due to its inefficacy. Some of the ligands, e.g., TAK-779 and TAK-652, were also found to be dual antagonists of CCR2 and C作者: Hay-Fever 時間: 2025-3-23 14:58
Book 2015roughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known 作者: debble 時間: 2025-3-23 20:16
Werner Dickmeis,Rolf Joachim Nesselpact of structures on rational molecular design initiatives. As an inherently challenging family of GPCRs, chemokine receptors may only reveal their secrets when tackled by the efficient symbiosis of computational approaches with experimental structure determination.作者: 商談 時間: 2025-3-24 01:26
https://doi.org/10.1007/978-3-322-87917-2ory processes fueled the use of CCR5 antagonists for the treatment of rheumatoid arthritis. Unfortunately, the use of maraviroc for the treatment of rheumatoid arthritis failed due to its inefficacy. Some of the ligands, e.g., TAK-779 and TAK-652, were also found to be dual antagonists of CCR2 and C作者: 支形吊燈 時間: 2025-3-24 06:20 作者: podiatrist 時間: 2025-3-24 06:57 作者: 膝蓋 時間: 2025-3-24 11:15
Chemokine Receptors in Allergy, Inflammation, and Infectious Disease,coupled receptors, which represent one of the most druggable classes of proteins. In this review we will examine the role of chemokines in autoimmunity and inflammation by concentrating on the part they play in the pathophysiology of several diseases including asthma, multiple sclerosis, and rheumat作者: 滲入 時間: 2025-3-24 16:27 作者: 沖突 時間: 2025-3-24 22:16 作者: 很像弓] 時間: 2025-3-25 00:54 作者: 瘋狂 時間: 2025-3-25 05:15 作者: Irksome 時間: 2025-3-25 07:28 作者: Additive 時間: 2025-3-25 14:02 作者: Evolve 時間: 2025-3-25 16:52
1862-2461 in the field.Volumes are useful and of relevance for a longMedicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need fo作者: 大氣層 時間: 2025-3-25 23:07 作者: MURKY 時間: 2025-3-26 01:36 作者: corn732 時間: 2025-3-26 07:11
7樓作者: relieve 時間: 2025-3-26 10:27
8樓作者: antiquated 時間: 2025-3-26 13:25
8樓作者: LATE 時間: 2025-3-26 19:15
8樓作者: Narrative 時間: 2025-3-27 00:51
9樓作者: Cuisine 時間: 2025-3-27 04:59
9樓作者: quiet-sleep 時間: 2025-3-27 05:23
9樓作者: LAVA 時間: 2025-3-27 10:47
9樓作者: 凈禮 時間: 2025-3-27 13:51
10樓作者: Yourself 時間: 2025-3-27 20:04
10樓作者: 機密 時間: 2025-3-27 22:44
10樓作者: 瑣事 時間: 2025-3-28 02:55
10樓
